/PRNewswire/ The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization".
The DNA Diagnostics Market generated US$ 20.9 billion in 2021 and is anticipated to grow by 9.6% year over year to reach US$ 22.9 billion in 2022. The industry is anticipated to increase to US$ 51.5 billion by 2032 as a result of the growing support from various governmental bodies. During the forecast period of 202.
According to a recent market analysis conducted by Future Market Insights (FMI), the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market was valued at US$ 3.8 billion in 2021 and is anticipated to reach US$ 5.5 billion by 2030.Sepsis, toxic shock syndrome, bacteremia, osteomyelitis, endocardit.
The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market was valued at US$ 3.8 Bn in 2021 and is expected to reach US$ 5.5 Bn by 2030, finds Future Market Insights (FMI) in a recent market survey.Sepsis, toxic shock syndrome, bacteremia, osteomyelitis, endocarditis, meningitis, pneumonia are am.